Whereas upregulation of PGC1α has been observed in the early phase of diabetes [113], PGC1α was suppressed in long-term diabetes and kidney tissues of patients with DKD [83,114,115,116] and other pro-fibrotic diseases [117]. This evidence concerns the gene PPARGC1A and diabetic kidney disease.